The Online Books Page

Pharmaceutical policy

See also what's at Wikipedia, your library, or elsewhere.

• Medical policy
• Drugs
• Pharmacy

• Pharmaceutical policy -- United States
• Drugs -- Law and legislation
• Older people -- Pharmaceutical assistance
• Pharmacy -- Law and legislation

• Drug policy
• Drugs and state
• Drugs -- Government policy
• Pharmacy and state
• Pharmacy -- Government policy
• State and drugs
• State and pharmacy

• Intellectual Property and Public Health in the Developing World (Cambridge, UK: Open Book Publishers, c2016), by Mohammad Monirul Azam (multiple formats with commentary at Open Book Publishers)

• Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
• Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open)
• Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (Washington: Office of Technology Assessment, 1992), by Alan M. Garber, Ann E. Clarke, Dana P. Goldman, and Michael E. Gluck (PDF files at Princeton)

• The Drug Hang-Up: America's Fifty-Year Folly, by Rufus King (HTML at druglibrary.org)

• Between Politics and Reason: The Drug Legalization Debate, by Erich Goode (HTML at druglibrary.org)

• An Offer You Can't Refuse: How US Federal Prosecutors Force Drug Defendants to Plead Guilty (New York et al.: Human Rights Watch, 2013), by Jamie Fellner (HTML and PDF with commentary at hrw.org)

• The Toadstool Millionaires: A Social History of Patent Medicines in America Before Federal Regulation, by James Harvey Young (HTML at quackwatch.com)

• Drug Labeling in Developing Countries (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Advice to Booksellers, Perfumers, &c. Not to Sell Any More Stamps with Their Medicines, (Patent Ones Excepted) Nor the Public to Pay for Them: Founded on Constitutional Principles, With Strictures on the Medicine Act, Respectfully Submitted to His Most Gracious Majesty, and Both Houses of Parliament (London: G. Wilkie, 1784), by F. B. Spilsbury (page images at NIH)

• Intellectual Property and Public Health in the Developing World (Cambridge, UK: Open Book Publishers, c2016), by Mohammad Monirul Azam (multiple formats with commentary at Open Book Publishers)

• Drug Labeling in Developing Countries (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Outpatient Immunosuppressive Drugs Under Medicare (OTA-H-452; 1991), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• Advice to Booksellers, Perfumers, &c. Not to Sell Any More Stamps with Their Medicines, (Patent Ones Excepted) Nor the Public to Pay for Them: Founded on Constitutional Principles, With Strictures on the Medicine Act, Respectfully Submitted to His Most Gracious Majesty, and Both Houses of Parliament (London: G. Wilkie, 1784), by F. B. Spilsbury (page images at NIH)

Items below (if any) are from related and broader terms.

• COVID-19 and World Order: The Future of Conflict, Competition, and Cooperation (Baltimore: Johns Hopkins University Press, c2020), ed. by Hal Brands and Francis J. Gavin (HTML and PDF files at Project MUSE)
• Healthy Incentives: Canadian Health Reform in an International Context (Vancouver: Fraser Institute, c1996), ed. by William McArthur, Cynthia Ramsay, and Michael Walker (PDF at Fraser Institute)

• Reshaping Health Care in Latin America: A Comparative Analysis of Health Care Reform in Argentina, Brazil, and Mexico, ed. by Sonia Fleury, Susana Belmartino, and Enis Baris (PDF and HTML with commentary at idrc.ca)

• Healthy Incentives: Canadian Health Reform in an International Context (Vancouver: Fraser Institute, c1996), ed. by William McArthur, Cynthia Ramsay, and Michael Walker (PDF at Fraser Institute)

• Health Care: A Community Concern? Developments in the Organization of Canadian Health Services (Calgary: University of Calgary Press, c1997), by Anne Crichton, Ann Robertson, Christine Gordon, and W. Farrant (PDF files at University of Calgary)
• Healthy Incentives: Canadian Health Reform in an International Context (Vancouver: Fraser Institute, c1996), ed. by William McArthur, Cynthia Ramsay, and Michael Walker (PDF at Fraser Institute)

• Biomedical Politics (Washington: National Academy Press, 1991), ed. by Kathi E. Hanna (multiple formats with commentary at NAP)

• Pathological Bodies: Medicine and Popular Culture (Berkeley et al.: Global, Area, and International Archive; University of California Press, c2013), by Corinna Wagner (page images and PDF with commentary at escholarship.org)

• Quite Like Heaven? Options for the NHS in a Consumer Age (c2007), by Nick Seddon (PDF at Civitas)

• Affordable Excellence: The Singapore Healthcare Story (Singapore: Ridge Books; Washington: Brookings Institution Press, c2013), by William A. Haseltine (PDF at brookings.edu)

• Healthy Communities: New Partnerships for the Future of Public Health (1996), ed. by Michael A. Stoto, Cynthia H. Abel, and Anne Dievler (page images with commentary at NAP)
• Health Policy and the Disadvantaged (Durham, NC and London: Duke University Press, 1991), ed. by Lawrence D. Brown (page images at HathiTrust)
• Allied Health Services: Avoiding Crises (1989), by Institute of Medicine (U.S.) (page images with commentary at NAP)
• The Nation's Physician Workforce: Options for Balancing Supply and Requirements (1996), by Institute of Medicine (U.S.) (HTML with commentary at NAP)
• Clinical Practice Guidelines: Directions for a New Program (1990), ed. by Marilyn J. Field and Kathleen N. Lohr (page images with commentary at NAP)
• The Artificial Heart: Cost, Risk, and Benefits (1982), by Deborah P. Lubeck and John P. Bunker (PDF files at Princeton)
• The Swine Flu Affair: Decision-Making on a Slippery Disease (Washington: U. S. Dept. of Health, Education, and Welfare, 1978), by Richard E. Neustadt and Harvey V. Fineberg, contrib. by Joseph A. Califano (page images at HathiTrust)
• Identifying Health Technologies That Work: Searching for Evidence (1994), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton
• Neurotoxins, at Home and the Workplace: Report to the Committee on Science and Technology, U.S. House of Representatives, Ninety-Ninth Congress, Second Session (Washington: GPO, 1989), by United States House Committee on Science and Technology (page images at HathiTrust)
• What, If Any, Should Government's Role Be Regarding Health Care in the United States? Excerpts from the 1992 Harry Singer Foundation Essay Contest, ed. by Margaret Bohannon-Kaplan (HTML at Wayback Machine)
• Policy Implications of the Computed Tomography (CT) Scanner: An Update (1981), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton
• Policy Implications of the Computed Tomography (CT) Scanner (1978), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton
• Policy Implications of Medical Information Systems (OTA-H-56; 1977), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF at Georgetown
• HIV and the Blood Supply: An Analysis of Crisis Decisionmaking (Washington: National Academy Press, 1995), ed. by Lauren B. Leveton, Harold J. Sox, and Michael A. Stoto (page images with commentary at NAP)
• Headline News, Science Views II (1993), ed. by David Jarmul (page images with commentary at NAP)
• Headline News, Science Views (1991), ed. by David Jarmul (page images with commentary at NAP)
• Medical Technology Under Proposals To Increase Competition in Health Care (1982), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files with commentary at Princeton
  • PDF at unt.edu
• The Implications of Cost-Effectiveness Analysis of Medical Technology (1980), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton
• Responding to Health Needs and Scientific Opportunity: The Organizational Structure of the National Institutes of Health, by Institute of Medicine (U.S.) (page images with commentary at NAP)
• National Priorities for the Assessment of Clinical Conditions and Medical Technologies, ed. by Marielena Lara and Clifford Goodman (page images with commentary at NAP)
• Taking a Stand on Health Care, by Helen P. Rogers (HTML at Wayback Machine)

• Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health (final commission report; Geneva: World Health Organization, 2008), by WHO Commission on Social Determinants of Health (PDF at who.int)

• 2020 Vision: Health in the 21st Century (1996), by Institute of Medicine (U.S.) (page images with commentary at NAP)
• Future Medicine: Ethical Dilemmas, Regulatory Challenges, and Therapeutic Pathways to Health Care and Healing in Human Transformation (Ann Arbor, MI: University of Michigan Press, c2003), by Michael H. Cohen (page images at HathiTrust)

• WHO QualityRights Tool Kit: Assessing and Improving Quality and Human Rights in Mental Health and Social Care Facilities (with supplementary documents; c2012), by World Health Organization (PDF with commentary at who.int)

• Appraisal of the Safety of Chemicals in Foods, Drugs, and Cosmetics (Austin, TX: Association of Food and Drug Officials of the United States, 1959), by United States Food and Drug Administration (page images at HathiTrust)

More items available under broader and related terms at left.